TY - JOUR
T1 - Mass spectrometric identification of urinary and plasma metabolites of 9-hydroxy-19,20-bis-nor-prostanoic acid (rosaprostol)
AU - Benfenati, E.
AU - Fanelli, R.
AU - Chiabrando, C.
AU - Valcavi, U.
AU - Bosone, E.
AU - Farina, P.
PY - 1988
Y1 - 1988
N2 - • 9-Hydroxy-19,20-bis-nor-prostanoic acid (Rosaprostol) is an antiulcer compound with antisecretory and cytoprotective action. We studied the metabolites of Rosaprostol found in human plasma and in human and rat urine. • Sixteen different metabolites were tentatively identified on the basis of their mass spectra. Two presumed metabolites were synthesized. To clarify the identities of some of them, deuterated Rosaprostol was administered to rats and mass spectra of the deuterated and protonated metabolites were examined. • Rosaprostal is metabolized following three metabolic pathways leading, combined, to oxidized compounds with a lower number of carbons than the parent drug.
AB - • 9-Hydroxy-19,20-bis-nor-prostanoic acid (Rosaprostol) is an antiulcer compound with antisecretory and cytoprotective action. We studied the metabolites of Rosaprostol found in human plasma and in human and rat urine. • Sixteen different metabolites were tentatively identified on the basis of their mass spectra. Two presumed metabolites were synthesized. To clarify the identities of some of them, deuterated Rosaprostol was administered to rats and mass spectra of the deuterated and protonated metabolites were examined. • Rosaprostal is metabolized following three metabolic pathways leading, combined, to oxidized compounds with a lower number of carbons than the parent drug.
UR - http://www.scopus.com/inward/record.url?scp=0023944009&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0023944009&partnerID=8YFLogxK
U2 - 10.1016/0090-6980(88)90141-4
DO - 10.1016/0090-6980(88)90141-4
M3 - Article
C2 - 3399677
AN - SCOPUS:0023944009
SN - 1098-8823
VL - 35
SP - 665
EP - 684
JO - Prostaglandins and Other Lipid Mediators
JF - Prostaglandins and Other Lipid Mediators
IS - 5
ER -